National and Kapodistrian University of Athens
Μελέτη των γονιδίων του καρκίνου του μαστού και των ωοθηκών BRCA1 και BRCA2 σε παιδιά με νεοπλασματικές παθήσεις και στις μητέρες τους
Abstract
dc:descriptionIntroduction: Breast and ovarian cancers are the most prevalent amongst women.The BRCA genes have found about 20 years ago and since great progress hasbeen achieved with respect to disease prognosis, diagnosis and treatment of breastand ovarian cancer. Yet, it is interesting, and troubling at the same time, that theincidence of breast and ovarian cancer increases with time something that couldattribute to the increase of life expectancy, environmental factors as well as hereditaryfactors. Similar incidence results appear in childhood malignancies, wherethe basic ontogenetic mechanisms still remain to be elucidated. Such approaches,of relating mothers’ mutations with the prevalence of childhood cancer in their offspringcould prove useful in the prognosis, early detection and therapy of childhoodmalignancies.Aim & Objectives: The aim of the present study was to investigate the incidenceof mutations in mothers with children suffering from neoplasms, whereas some ofthem have been patients for neoplasms themselves. For that purpose we havestudied mutations in known genes, already known for their role in carcinogenesis,such as BRCA, some of the RAS family genes, TP53 and FLT3, which is known forhis role in childhood acute leukemia. Further on, the present study aimed at theinvestigation of a probable hereditary mechanism of oncogenesis, which couldprobably predict the risk for neoplasm disease in children based on the mother’sgenetic profile. Such tools could prove very useful in the therapy of childhood malignanciesa potential links between mothers’ mutations and children could help todisease prognosis at the very early stages of the disease. The present study had apreliminary character, in such a way that aimed in giving the first correlation betweencancers in mothers to cancer in their children.Materials and Methods: The target group consisted of mothers whose childrenhad been hospitalized due to the incidence of cancer. At the same time some of themothers had been patients themselves for breast cancer and/or there was a familyhistory of cancer in the family. Genes were examined for mutations and in particular,those were BRCA1, RAS family genes, TP53 and FLT3. Mutations were initiallydetected using PCR and multiplex PCR methodologies. Gene expression wasdetected using qRT-PCR methodologies and results have been confirmed with thesequencing method. Following experimental analysis, bioinformatics analyses hasbeen performed. In the case of positive identification of mutations, molecular modellingwas used in order to study the effects of the mutations on the BRCA proteinand subsequent effects on binding to BARD1, a signaling molecule down-stream ofBRCA1, which participates in DNA repair pathways.Results: PCR methods detected a prevalence of BRCA1 up to 17% and 11% for exons2 and 20 respectively. KRAS mutations were up to 8% and 10% for exons 1 and2 respectively. TP53 mutations reached a 10% level. These findings were revealedusing PCR methodologies. Confirming those results with sequencing methods revealedthat some of the results were false positives, whereas almost half of the positivesamples did had a BRCA1 mutation. No mutations were found for BRCA2.Those results are in agreement with other studies both in the Greek population aswell as other ethnicities. It appeared that there was no positive correlation betweenmothers’ incidence of mutations with those of the children’s’. On the contrarythere was a negative correlation between those two factors indicating thatmothers’ mutation does necessarily affect the child’s neoplasmatic phenotype.Gene expression showed that BRCA1 and KRAS were in most cases down regulated,in agreement with other studies confirming the role of BRCA1 as a tumor suppressorgene. Finally, it appeared that BRCA1 mutations do affect the binding ofthe protein to BARD1, which consequently affects the function of the DNA repairpathway.Conclusions: Concluding, it appeared that the presence of a mutation in theaforementioned genes is not adequate for the disease to progress, yet it can beconsidered as a serious factor for disease progression. Further on, it appears thatthe negative correlation between mothers’ incidence of mutations and that of thechildren’s is specific only for obstetrical neoplasms and not for childhood neoplasms.Overall the final mother population was small due to the fact that breastand ovarian cancer present a peak around the age of 60, where children havereached adulthood. Thus, mothers that had young children hospitalized for cancerwere young and therefore the incidence of neoplasm within the mother populationwas small. Yet, it appears that this phenomenon is of extreme interest and it should be further investigated in a larger patient cohort.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2015
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Barbounaki, Ioanna
- Μπαρμπουνάκη, Ιωάννα
Subjects
dc:subject × 16Rights
dc:rights- Statement dc:rights
-
- BY_NC_SA
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/42552